Northern Trust’s BioSpecifics Technologies Corp. BSTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-96,310
| Closed | -$5.09M | – | 4446 |
|
|
2020
Q3 | $5.09M | Sell |
96,310
-2,918
| -3% | -$180K | ﹤0.01% | 2519 |
|
|
2020
Q2 | $6.08M | Sell |
99,228
-2,191
| -2% | -$127K | ﹤0.01% | 2396 |
|
|
2020
Q1 | $5.74M | Buy |
101,419
+2,188
| +2% | +$125K | ﹤0.01% | 2214 |
|
|
2019
Q4 | $5.65M | Sell |
99,231
-4,541
| -4% | -$241K | ﹤0.01% | 2507 |
|
|
2019
Q3 | $5.55M | Buy |
103,772
+9,563
| +10% | +$557K | ﹤0.01% | 2488 |
|
|
2019
Q2 | $5.63M | Buy |
94,209
+1,278
| +1% | +$80.4K | ﹤0.01% | 2499 |
|
|
2019
Q1 | $5.79M | Buy |
92,931
+388
| +0.4% | +$25.7K | ﹤0.01% | 2475 |
|
|
2018
Q4 | $5.61M | Sell |
92,543
-1,894
| -2% | -$113K | ﹤0.01% | 2429 |
|
|
2018
Q3 | $5.52M | Buy |
94,437
+3,015
| +3% | +$154K | ﹤0.01% | 2627 |
|
|
2018
Q2 | $4.1M | Buy |
91,422
+2,566
| +3% | +$110K | ﹤0.01% | 2790 |
|
|
2018
Q1 | $3.94M | Buy |
88,856
+999
| +1% | +$42K | ﹤0.01% | 2726 |
|
|
2017
Q4 | $3.81M | Buy |
87,857
+1,763
| +2% | +$79.2K | ﹤0.01% | 2769 |
|
|
2017
Q3 | $4M | Buy |
86,094
+1,561
| +2% | +$74.7K | ﹤0.01% | 2769 |
|
|
2017
Q2 | $4.18M | Buy |
84,533
+4,351
| +5% | +$228K | ﹤0.01% | 2730 |
|
|
2017
Q1 | $4.39M | Sell |
80,182
-949
| -1% | -$50.2K | ﹤0.01% | 2631 |
|
|
2016
Q4 | $4.52M | Buy |
81,131
+1,296
| +2% | +$62.3K | ﹤0.01% | 2608 |
|
|
2016
Q3 | $3.65M | Buy |
79,835
+1,666
| +2% | +$66.9K | ﹤0.01% | 2734 |
|
|
2016
Q2 | $3.12M | Buy |
78,169
+2,395
| +3% | +$87.7K | ﹤0.01% | 2778 |
|
|
2016
Q1 | $2.64M | Buy |
75,774
+3,489
| +5% | +$128K | ﹤0.01% | 2815 |
|
|
2015
Q4 | $3.11M | Buy |
72,285
+1,032
| +1% | +$51.7K | ﹤0.01% | 2779 |
|
|
2015
Q3 | $3.1M | Buy |
71,253
+9,412
| +15% | +$508K | ﹤0.01% | 2777 |
|
|
2015
Q2 | $3.19M | Buy |
61,841
+335
| +0.5% | +$14.3K | ﹤0.01% | 2803 |
|
|
2015
Q1 | $2.41M | Sell |
61,506
-992
| -2% | -$38.9K | ﹤0.01% | 3014 |
|
|
2014
Q4 | $2.41M | Buy |
62,498
+3,303
| +6% | +$126K | ﹤0.01% | 2986 |
|
|
2014
Q3 | $2.09M | Buy |
59,195
+27,750
| +88% | +$815K | ﹤0.01% | 3071 |
|
|
2014
Q2 | $848K | Buy |
31,445
+3,722
| +13% | +$97K | ﹤0.01% | 3461 |
|
|
2014
Q1 | $719K | Buy |
27,723
+1,676
| +6% | +$40.2K | ﹤0.01% | 3469 |
|
|
2013
Q4 | $565K | Buy |
26,047
+1,608
| +7% | +$32.9K | ﹤0.01% | 3493 |
|
|
2013
Q3 | $476K | Sell |
24,439
-43,613
| -64% | -$773K | ﹤0.01% | 3470 |
|
|
2013
Q2 | $1.06M | Buy |
+68,052
| New | +$1.09M | ﹤0.01% | 3252 |
|
Other funds holding BSTC
Northern Trust's BSTC Position: Q4 2020 in Review
Northern Trust sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 96,310 shares — an estimated $5.09M sold.
Northern Trust first reported a position in BSTC in Q2 2013 and held it in 30 quarters. The position peaked at $6.08M in Q2 2020. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.
- Northern Trust reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
- Northern Trust sold 96,310 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $5.09M.
- Northern Trust first reported a position in BioSpecifics Technologies Corp. in Q2 2013 and held it in 30 quarters.
- Northern Trust's BioSpecifics Technologies Corp. position peaked at $6.08M in Q2 2020.
- 1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.
Based on Northern Trust's 13F filing for Q4 2020, filed 11 Feb 2021.